Skip to main content
. 2021 Apr 12;5:29. doi: 10.1038/s41698-021-00166-3

Table 1.

List of lung cancer samples used for this study.

Case Sample number Sex Age Lung cancer type Subtype Stage Sample type Organoid formation Tumoroid formation Driver oncogene Passage number
1 L1 M 80 Small cell carcinoma pStage IA3 Surgical specimen X N/A
2 L2 M 76 Adenocarcinoma pStage IIIA Surgical specimen X N/A
3 L3 M 79 Adenocarcinoma Acinar pStage IA2 Surgical specimen X N/A
4 L4 F 56 Adenocarcinoma Acinar pStage IVA Surgical specimen X EGFR (Exon 18 G719S) N/A
5 L5 M 73 Adenocarcinoma Solid pStage IA2 Surgical specimen More than 22 months, passage >92
6 L6 F 77 Adenocarcinoma Mucinous pStage IB Surgical specimen X N/A
7 L7 M 76 Squamous cell carcinoma Poor pStage IIB Surgical specimen X N/A
8 L8 F 75 Adenocarcinoma pStage IA3 Surgical specimen X N/A
9 L9 M 79 Adenocarcinoma Papillary pStage IA2 Surgical specimen X N/A
10 L10 F 82 Adenocarcinoma cStage IVA Pleural effusion X X N/A
11 L11 M 75 Adenocarcinoma Papillary pStage IIA Surgical specimen X EGFR (Exon 21 L858R) N/A
12 L12 M 69 Adenocarcinoma Lepidic pStage IA2 Surgical specimen X EGFR (Exon 21 L858R) N/A
13 L13 F 70 Adenocarcinoma pStage IIA Surgical specimen X EGFR (Exon 21 L858R) N/A
14 L14 M 83 Adenocarcinoma Solid pStage IB Surgical specimen X N/A
15 L15 M 62 Adenocarcinoma pStage IA1 Surgical specimen X EGFR (Exon 18 G719A) N/A
16 L16 M 77 Squamous cell carcinoma Moderate pStage IA2 Surgical specimen X N/A
17 L17 M 69 Adenocarcinoma Lepidic pStage IA2 Surgical specimen X EGFR (Exon 21 L858R) N/A
18 L18 M 75 Adenocarcinoma Solid pStage IA3 Surgical specimen X EGFR (Exon 19 del) N/A
19 L19 F 65 Adenocarcinoma Acinar pStage IIIA Surgical specimen More than 22 months, passage >86
20 L20 M 81 Squamous cell carcinoma pStage IB Surgical specimen X N/A
21 L21 F 70 Adenocarcinoma Mucinous pStage IA2 Surgical specimen X N/A
22 L23 M 77 Adenocarcinoma pStage IA2 Surgical specimen X N/A
23 L24 M 69 Adenocarcinoma Acinar pStage IA2 Surgical specimen X EGFR (Exon 18 G719A, S720Y) N/A
24 L25 F 56 Adenocarcinoma in situ pStage 0 Surgical specimen X EGFR (Exon 18 G719S) N/A
25 L26 F 70 Adenocarcinoma Lepidic pStage IA1 Surgical specimen X N/A
26 L27 M 58 Adenocarcinoma Mucinous pStage IIIA Surgical specimen X N/A
27 L28 M 52 Adenocarcinoma Acinar pStage IIIA Surgical specimen X N/A
28 L29 F 74 Pleomorphic carcinoma pStage IB Surgical specimen X N/A
29 L30 M 71 Squamous cell carcinoma Moderate pStage IIA Surgical specimen X N/A
30 L31 M 84 Adenocarcinoma Papillary pStage IA1 Surgical specimen X X N/A
31 L32 F 72 Adenocarcinoma Lepidic pStage IA1 Surgical specimen X N/A
32 L33 F 50 Adenocarcinoma Lepidic pStage IA2 Surgical specimen X N/A
33 L34 M 77 Squamous cell carcinoma pStage IIIA Surgical specimen X N/A
34 L35 M 70 Small cell carcinoma pStage IB Surgical specimen X X N/A
35 L37 M 86 Pleomorphic carcinoma pStage IIB Surgical specimen X X EGFR (Exon 19 del) N/A
36 L38 F 71 Adenocarcinoma Lepidic pStage IA1 Surgical specimen X X N/A
37 L39 F 77 Squamous cell carcinoma pStage IIA Surgical specimen X N/A
38 L40 F 86 Adenocarcinoma pStage IIIA Surgical specimen X X N/A
39 L41 M 70 Adenocarcinoma T2aNxMx Surgical specimen X X N/A
40 L42 M 77 Squamous cell carcinoma pStage IIA Surgical specimen X N/A
41 L43 F 73 Adenocarcinoma pStage IVB Pleural effusion EGFR (Exon 20 T790M loss, Exon 21 L858R) >13 months, passage >36